Market Overview:
The global asthma treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of asthma, rising awareness about asthma treatments, and technological advancements in the field of asthma treatment. Based on type, the global asthma treatment market is segmented into breathing exercises, rescue/first aid treatments, long-term asthma control medications, and monoclonal antibody therapies. The long-term asthma control medications segment is expected to grow at a CAGR of 6.1% from 2018 to 2030 due to the increasing adoption of these therapies by patients across the globe. Based on application, the global asthmatic therapy market is divided into mild intermittent asthmatics (MIA), mild persistent asthmatics (MPA), moderate persistent asthmatics (MPA), and severe persistent asthmatics (SPA).
Product Definition:
Asthma Treatment is the use of medications and other interventions to prevent and control asthma symptoms. Asthma Treatment is important because it can help people with asthma to breathe better, feel better, and live fuller lives.
Breathing Exercises:
Breathing exercises are a group of physical activities that help in improving the lung capacity. These activities also increase the oxygen supply to the blood and improve its ability to carry out its function of transporting oxygen to tissues and organs. The breathing exercises can be done either individually or with the help of a fitness instructor or yoga master. It is very much clear that regular breathing exercise increases lung capacity, but it is not known whether these practices have any effect on asthma treatment as well as prevention.
Rescue/First Aid Treatments:
Rescue/First Aid Treatments.
The global rescue/first aid treatments and it's usage in asthma treatment market size was valued at USD 6.5 billion in 2015. The increasing prevalence of respiratory diseases coupled with rising awareness regarding first aid treatments is expected to drive the growth over the forecast period.
Application Insights:
The moderate and severe persistent asthma segment dominated the global market in terms of revenue share in 2017. The increasing prevalence of asthma and rising awareness about its treatment are factors responsible for the high share held by this segment. According to a study published in NCBI, it is estimated that around 54 million people suffered from asthma across the globe and approximately 1.7 million died due to it in 2015.
In addition, according to WHO, around 463 thousand deaths occur every year due to air pollution caused by wood smoke which is expected to increase with time as well as other sources such as motor vehicles and industrial emissions contributing towards a large number of deaths each year globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high awareness levels regarding asthma management, and availability of highly effective treatment methods for asthma control. The region is expected to maintain its dominance throughout the forecast period owing to factors such as favorable reimbursement policies and increasing prevalence of asthma.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising healthcare expenditure by governments and private organizations, improving healthcare infrastructure & coverage, growing patient awareness about available treatments & access to care settings along with rising prevalence rates associated with allergies among other factors. In addition, an increase in disposable income levels will also contribute toward regional growth during the same period (2018-2030). ‘’ Asthma Canada Asthma Society ‘’s mission is ToAsthmaFreeThe WorldBy 2025 '.
Growth Factors:
- Increasing prevalence of asthma: The global prevalence of asthma is increasing every year. This is mainly due to the changing lifestyle and environmental factors. As per the World Health Organization (WHO), around 300 million people are affected by asthma worldwide. This number is expected to increase in the coming years, thereby driving the growth of Asthma Treatment market.
- Growing awareness about asthma: There is a growing awareness among people about asthma and its treatment options. This has led to an increase in the number of people seeking treatment for this respiratory disorder. Thus, there is a high potential for growth in Asthma Treatment market in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Asthma Treatment Market Research Report
By Type
Breathing Exercises, Rescue/First Aid Treatments, Long-Term Asthma Control Medications, Monoclonal Antibody
By Application
Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent
By Companies
AstraZeneca, GSK, Novartis, Boehringer Ingelheim, Merck & Co. Inc, Roche Holdings Ltd, Sunovion Pharmaceuticals Inc, Schering-Plough Corp, Sanofi, Theravance Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Asthma Treatment Market Report Segments:
The global Asthma Treatment market is segmented on the basis of:
Types
Breathing Exercises, Rescue/First Aid Treatments, Long-Term Asthma Control Medications, Monoclonal Antibody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- GSK
- Novartis
- Boehringer Ingelheim
- Merck & Co. Inc
- Roche Holdings Ltd
- Sunovion Pharmaceuticals Inc
- Schering-Plough Corp
- Sanofi
- Theravance Inc
Highlights of The Asthma Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Breathing Exercises
- Rescue/First Aid Treatments
- Long-Term Asthma Control Medications
- Monoclonal Antibody
- By Application:
- Mild Intermittent
- Mild Persistent
- Moderate Persistent
- Severe Persistent
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Asthma Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Asthma treatment is a combination of medications and lifestyle changes that help to improve air flow and reduce inflammation in the lungs. Treatment may include using an inhaler, corticosteroids, or a bronchodilator.
Some of the major players in the asthma treatment market are AstraZeneca, GSK, Novartis, Boehringer Ingelheim, Merck & Co. Inc, Roche Holdings Ltd, Sunovion Pharmaceuticals Inc, Schering-Plough Corp, Sanofi, Theravance Inc.
The asthma treatment market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Asthma Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Asthma Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Asthma Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Asthma Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Asthma Treatment Market Size & Forecast, 2018-2028
4.5.1 Asthma Treatment Market Size and Y-o-Y Growth
4.5.2 Asthma Treatment Market Absolute $ Opportunity
Chapter 5 Global Asthma Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Asthma Treatment Market Size Forecast by Type
5.2.1 Breathing Exercises
5.2.2 Rescue/First Aid Treatments
5.2.3 Long-Term Asthma Control Medications
5.2.4 Monoclonal Antibody
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Asthma Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Asthma Treatment Market Size Forecast by Applications
6.2.1 Mild Intermittent
6.2.2 Mild Persistent
6.2.3 Moderate Persistent
6.2.4 Severe Persistent
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Asthma Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Asthma Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Asthma Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Asthma Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Asthma Treatment Market Size Forecast by Type
9.6.1 Breathing Exercises
9.6.2 Rescue/First Aid Treatments
9.6.3 Long-Term Asthma Control Medications
9.6.4 Monoclonal Antibody
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Asthma Treatment Market Size Forecast by Applications
9.10.1 Mild Intermittent
9.10.2 Mild Persistent
9.10.3 Moderate Persistent
9.10.4 Severe Persistent
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Asthma Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Asthma Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Asthma Treatment Market Size Forecast by Type
10.6.1 Breathing Exercises
10.6.2 Rescue/First Aid Treatments
10.6.3 Long-Term Asthma Control Medications
10.6.4 Monoclonal Antibody
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Asthma Treatment Market Size Forecast by Applications
10.10.1 Mild Intermittent
10.10.2 Mild Persistent
10.10.3 Moderate Persistent
10.10.4 Severe Persistent
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Asthma Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Asthma Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Asthma Treatment Market Size Forecast by Type
11.6.1 Breathing Exercises
11.6.2 Rescue/First Aid Treatments
11.6.3 Long-Term Asthma Control Medications
11.6.4 Monoclonal Antibody
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Asthma Treatment Market Size Forecast by Applications
11.10.1 Mild Intermittent
11.10.2 Mild Persistent
11.10.3 Moderate Persistent
11.10.4 Severe Persistent
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Asthma Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Asthma Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Asthma Treatment Market Size Forecast by Type
12.6.1 Breathing Exercises
12.6.2 Rescue/First Aid Treatments
12.6.3 Long-Term Asthma Control Medications
12.6.4 Monoclonal Antibody
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Asthma Treatment Market Size Forecast by Applications
12.10.1 Mild Intermittent
12.10.2 Mild Persistent
12.10.3 Moderate Persistent
12.10.4 Severe Persistent
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Asthma Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Asthma Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Asthma Treatment Market Size Forecast by Type
13.6.1 Breathing Exercises
13.6.2 Rescue/First Aid Treatments
13.6.3 Long-Term Asthma Control Medications
13.6.4 Monoclonal Antibody
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Asthma Treatment Market Size Forecast by Applications
13.10.1 Mild Intermittent
13.10.2 Mild Persistent
13.10.3 Moderate Persistent
13.10.4 Severe Persistent
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Asthma Treatment Market: Competitive Dashboard
14.2 Global Asthma Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 GSK
14.3.3 Novartis
14.3.4 Boehringer Ingelheim
14.3.5 Merck & Co. Inc
14.3.6 Roche Holdings Ltd
14.3.7 Sunovion Pharmaceuticals Inc
14.3.8 Schering-Plough Corp
14.3.9 Sanofi
14.3.10 Theravance Inc
